TEVA B1 Pill - yellow round, 6mm
Pill with imprint TEVA B1 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Letrozole is used in the treatment of Breast Cancer, Adjuvant; Breast Cancer; Breast Cancer, Metastatic and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for TEVA B1
Letrozole
- Imprint
- TEVA B1
- Strength
- 2.5 mg
- Color
- Yellow
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Aromatase inhibitors, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc
- Inactive Ingredients
-
silicon dioxide,
FD&C Blue No. 2,
indigotindisulfonate sodium,
FD&C Yellow No. 5,
ferric oxide yellow,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol 3350,
polyethylene glycol 4000,
sodium starch glycolate type A potato,
corn starch,
magnesium silicate,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-7620 | Teva Pharmaceuticals USA, Inc. |
| 42291-0374 | AvKare, Inc. |
More about letrozole
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (367)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: aromatase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.